Expression of Preferentially Expressed Antigen in Melanoma, a Cancer/Testis Antigen, in Carcinoma In Situ of the Urinary Tract

Expression of Preferentially Expressed Antigen in Melanoma, a Cancer/Testis Antigen, in Carcinoma In Situ of the Urinary Tract

Carcinoma in situ (CIS) of the urinary tract comprises 1–3% of all urothelial malignancies and is often a precursor to muscle-invasive urothelial carcinoma (UC). This study aimed to examine the expression profiles of preferentially expressed antigen in melanoma (PRAME), a cancer/testis antigen, and...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों: Shota Fujii, Mitsuaki Ishida, Kazumasa Komura, Kazuki Nishimura, Takuya Tsujino, Tomohito Saito, Yohei Taniguchi, Tomohiro Murakawa, Haruhito Azuma, Yoshinobu Hirose
स्वरूप: लेख
भाषा:English
प्रकाशित: MDPI AG 2023-12-01
श्रृंखला:Diagnostics
विषय:
urothelial carcinoma
carcinoma in situ
preferentially expressed antigen in melanoma
ऑनलाइन पहुंच:https://www.mdpi.com/2075-4418/13/24/3636

इंटरनेट

https://www.mdpi.com/2075-4418/13/24/3636

समान संसाधन